A multifaceted approach to modeling the immune response in tuberculosis

Wiley Interdisciplinary Reviews: Systems Biology and Medicine

Volumn 3, Issue 4, 2011, Pages 479-489

  Marino, Simeone ^a   Linderman, Jennifer J ^b   Kirschner, Denise E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOLOGICAL MODEL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PATHOPHYSIOLOGY; TUBERCULOSIS;

HOST-PATHOGEN INTERACTIONS; HUMANS; MODELS, BIOLOGICAL; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

EID: 79960290056     PISSN: 19395094     EISSN: 1939005X     Source Type: Journal    
DOI: 10.1002/wsbm.131     Document Type: Article

References (58)

1. Kumar V, Robbins SL. Robbins Basic Pathology. 8th ed. Philadelphia, PA: Saunders/Elsevier; 2007.
2. Onyebujoh PR, Graham AW. World Health Organization Disease Watch: Focus: Tuberculosis. 2004 (Accessed October 7, 2006).
3. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 1994, 271:698-702.
4. Murphy BM, Singer BH, Anderson S, Kirschner D. Comparing epidemic tuberculosis in demographically distinct heterogeneous populations. Math Biosci 2002, 180:161-185.
5. Chang ST, Linderman JJ, Kirschner DE. Effect of multiple genetic polymorphisms on antigen presentation and susceptibility to Mycobacterium tuberculosis infection. Infect Immun 2008, 76:3221-3232.
6. Young D, Stark J, Kirschner D. Systems biology of persistent infection: tuberculosis as a case study. Nat Rev Microbiol 2008, 6:520-528.
7. Houben EN, Nguyen L, Pieters J. Interaction of pathogenic mycobacteria with the host immune system. Curr Opin Microbiol 2006, 9:76-85.
8. Cox RA. Quantitative relationships for specific growth rates and macromolecular compositions of Mycobacterium tuberculosis, Streptomyces coelicolor A3(2) and Escherichia coli B/r: an integrative theoretical approach. Microbiology 2004, 150(Pt 5):1413-1426.
9. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001, 19:93-129.
10. Fuller CL, Flynn JL, Reinhart TA. In situ study of abundant expression of proinflammatory chemokines and cytokines in pulmonary granulomas that develop in cynomolgus macaques experimentally infected with Mycobacterium tuberculosis. Infect Immun 2003, 71:7023-7034.
11. Lin PL, Myers A, Smith L, Bigbee C, Bigbee M, Fuhrman C, Grieser H, Chiosea I, Voitenek NN, Capuano SV, et al. Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. Arthritis Rheum 2010, 62:340-350.
12. Diedrich CR, Mattila JT, Klein E, Janssen C, Phuah J, Sturgeon TJ, Montelaro RC, Lin PL, Flynn JL. Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load. PLoS One 2010, 5:e9611.
13. Flynn JL, Chan J. What's good for the host is good for the bug. Trends Microbiol 2005, 13:98-102.
14. Lin PL, Pawar S, Myers A, Pegu A, Fuhrman C, Reinhart TA, Capuano SV, Klein E, Flynn JL. Early events in Mycobacterium tuberculosis infection in cynomolgus macaques. Infect Immun 2006, 74:3790-3803.
15. Lin PL, Rodgers M, Smith L, Bigbee M, Myers A, Bigbee C, Chiosea I, Capuano SV, Fuhrman C, Klein E. Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect Immun 2009, 77:4631-4642.
16. Kaufmann SH. Protection against tuberculosis: cytokines, T cells, and macrophages. Ann Rheum Dis 2002, 61(suppl 2):ii54-58.
17. Grosset J. Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary. Antimicrob Agents Chemother 2003, 47:833-836.
18. Chang ST, Ghosh D, Kirschner DE, Linderman JJ. Peptide length-based prediction of peptide-MHC class II binding. Bioinformatics 2006, 22:2761-2767.
19. Chakraborty AK, Kosmrlj A. Statistical mechanical concepts in immunology. Annu Rev Phys Chem 2010, 61:283-303.
20. Chang ST, Linderman JJ, Kirschner DE. Multiple mechanisms allow Mycobacterium tuberculosis to continuously inhibit MHC class II-mediated antigen presentation by macrophages. Proc Natl Acad Sci U S A 2005, 102:4530-4535.
21. Linderman JJ, Riggs T, Pande M, Miller M, Marino S, Kirschner DE. Characterizing the dynamics of CD4+T cell priming within a lymph node. J Immunol 2010, 184:2873-2885.
22. Riggs T, Walts A, Perry N, Bickle L, Lynch JN, Myers A, Flynn J, Linderman JJ, Miller MJ, Kirschner DE. A comparison of random vs. chemotaxis-driven contacts of T cells with dendritic cells during repertoire scanning. J Theor Biol 2008, 250:732-751.
23. Baldazzi V, Paci P, Bernaschi M, Castiglione F. Modeling lymphocyte homing and encounters in lymph nodes. BMC Bioinformatics 2009, 10:387.
24. Beltman JB, Maree AF, Lynch JN, Miller MJ, de Boer RJ. Lymph node topology dictates T cell migration behavior. J ExpMed 2007, 204:771-780.
25. Bogle G, Dunbar PR. Simulating T-cell motility in the lymph node paracortex with a packed lattice geometry. Immunol Cell Biol 2008, 86:676-687.
26. Bogle G, Dunbar PR. Agent-based simulation of T-cell activation and proliferation within a lymph node. Immunol Cell Biol 2010, 88:172-179.
27. Jansson A, Harlen M, Karlsson S, Nilsson P, Cooley M. 3D computation modelling of the influence of cytokine secretion on Th-cell development suggests that negative selection (inhibition of Th1 cells) is more effective than positive selection by IL-4 for Th2 cell dominance. Immunol Cell Biol 2007, 85:189-196.
28. Zheng H, Jin B, Henrickson SE, Perelson AS, von Andrian UH, Chakraborty AK. How antigen quantity and quality determine T-cell decisions in lymphoid tissue. Mol Cell Biol 2008, 28:4040-4051.
29. Fallahi-Sichani M, Schaller MA, Kirschner DE, Kunkel SL, Linderman JJ. Identification of key processes that control tumor necrosis factor availability in a tuberculosis granuloma. PLoS Comput Biol 2010, 6:e1000778.
30. Ray JC, Flynn JL, Kirschner DE. Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection. J Immunol 2009, 182:3706-3717.
31. Segovia-Juarez JL, Ganguli S, Kirschner D. Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model. J Theor Biol 2004, 231:357-376.
32. Warrender C, Forrest S, Koster F. Modeling intercellular interactions in early Mycobacterium infection. Bull Math Biol 2006, 68:2233-2261.
33. Ganguli S, Gammack D, Kirschner DE. A metapopulation model of granuloma formation in the lung during infection with Mycobacterium tuberculosis. Math Biosci Eng 2005, 2:535-560.
34. Gammack D, Doering CR, Kirschner DE. Macrophage response to Mycobacterium tuberculosis infection. J Math Biol 2004, 48:218-242.
35. Marino S, Sud D, Plessner H, Lin PL, Chan J, Flynn JL, Kirschner DE. Differences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavailability in granulomatous tissue. PLoS Comput Biol 2007, 3:1909-1924.
36. Sud D, Bigbee C, Flynn JL, Kirschner DE. Contribution of CD8+T cells to control of Mycobacterium tuberculosis infection. J Immunol 2006, 176:4296-4314.
37. Wigginton JE, Kirschner D. A model to predict cellmediated immune regulatory mechanisms during human infection with Mycobacterium tuberculosis. J Immunol 2001, 166:1951-1967.
38. Magombedze G, Garira W, Mwenje E. Modelling the human immune response mechanisms to Mycobacterium tuberculosis infection in the lungs. Math Biosci Eng 2006, 3:661-682.
39. Day J, Friedman A, Schlesinger LS. Modeling the immune rheostat of macrophages in the lung in response to infection. Proc Natl Acad Sci U S A 2009, 106: 11246-11251.
40. Marino S, Kirschner DE. The human immune response to Mycobacterium tuberculosis in lung and lymph node. J Theor Biol 2004, 227:463-486.
41. Marino S, Myers A, Flynn JL, Kirschner DE. TNF and IL-10 are major factors in modulation of the phagocytic cell environment in lung and lymph node in tuberculosis: a next-generation two-compartmental model. J Theor Biol 2010, 265:586-598.
42. Marino S, Pawar S, Fuller CL, Reinhart TA, Flynn JL, Kirschner DE. Dendritic cell trafficking and antigen presentation in the human immune response to Mycobacterium tuberculosis. J Immunol 2004, 173:494-506.
43. Bajaria SH, Webb G, Cloyd M, Kirschner D. Dynamics of naive and memory CD4+T lymphocytes in HIV-1 disease progression. J Acquir Immune Defic Syndr 2002, 30:41-58.
44. Bajaria SH, Webb G, Kirschner DE. Predicting differential responses to structured treatment interruptions during HAART. Bull Math Biol 2004, 66:1093-1118.
45. Hogue IB, Bajaria SH, Fallert BA, Qin S, Reinhart TA, Kirschner DE. The dual role of dendritic cells in the immune response to human immunodeficiency virus type 1 infection. J Gen Virol 2008, 89(Pt 9): 2228-2239.
46. Noble D. The Music of Life: Biology Beyond the Genome. Oxford, New York: Oxford University Press; 2006.
47. Dahari H, Layden-Almer JE, Kallwitz E, Ribeiro RM, Cotler SJ, Layden TJ, Perelson AS. A mathematical model of hepatitis C virus dynamics in patients with high baseline viral loads or advanced liver disease. Gastroenterology 2009, 136:1402-1409.
48. Wodarz D, Nowak MA. Mathematical models of HIV pathogenesis and treatment. Bioessays 2002, 24: 1178-1187.
49. Marino S, Hogue IB, Ray CJ, Kirschner DE. A methodology for performing global uncertainty and sensitivity analysis in systems biology. J Theor Biol 2008, 254:178-196.
50. Jung YJ, Ryan L, LaCourse R, North RJ. Increased interleukin-10 expression is not responsible for failure of T helper 1 immunity to resolve airborne Mycobacterium tuberculosis infection in mice. Immunology 2003, 109:295-299.
51. Turner J, Gonzalez-Juarrero M, Ellis DL, Basaraba RJ, Kipnis A, Orme IM, Cooper AM. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J Immunol 2002, 169:6343-6351.
52. Higgins DM, Sanchez-Campillo J, Rosas-Taraco AG, Lee EJ, Orme IM, Gonzalez-Juarrero M. Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. Tuberculosis (Edinb) 2009, 89:149-157.
53. Seiden PE, Celada F. A model for simulating cognate recognition and response in the immune system. J Theor Biol 1992, 158:329-357.
54. Bauer AL, Beauchemin CA, Perelson AS. Agent-based modeling of host-pathogen systems: the successes and challenges. Inf Sci (Ny) 2009, 179:1379-1389.
55. Multiscale Modeling Working Group. Available at: http://www.imagwiki.org/mediawiki/index.php?title=Multiscale_Modeling_Working_Groups.2010 (Accessed May 1, 2007).
56. Meier-Schellersheim M, Fraser IDC, Klauschen F. Multiscale modeling for biologists. Wiley Interdisciplinary Reviews: Systems Biology and Medicine, WIREs Syst Biol Med. John Wiley & Sons, Inc. 2009, 1:4-14.
57. Merryn H. Tawhai, Eric A. Hoffman and Ching-Long Lin. The lung physiome: merging imaging-based measures with predictive computational models. Wiley Interdisciplinary Reviews: Systems Biology and Medicine, WIREs Syst Biol Med. John Wiley & Sons, Inc., 2009, 1:61-72.
58. Gary An, Qi Mi, Joyeeta Dutta-Moscato, Yoram Vodovotz. Agent-based models in translational systems biology. Overview. Wiley Interdisciplinary Reviews: Systems Biology and Medicine, WIREs Syst Biol Med. John Wiley & Sons, Inc., 2009, 1:159-171.